Comparison of the Psoriatic Arthritis Quality of Life (PsAQoL) questionnaire, the functional status (HAQ) and utility (EQ-5D) measures in psoriatic arthritis: Results from a cross-sectional survey

Scandinavian Journal of Rheumatology

Volumn 39, Issue 4, 2010, Pages 303-309

  Brodszky, V ^a   Pentek M ^b   Blint, P V ^a   Geher P ^a   Hajdu, O ^a   Hodinka, L ^a   Horvth, G ^c   Koo E ^a   Polgr, A ^a   Sesztk, M ^a   Sznt, S ^b   Ujfalussy, I ^d   Gulcsi, L ^a  

^a Institute of Data Analytics and Information Systems   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d State Health Centre   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

28 JOINT SISEASE ACTIVITY SCORE; ADULT; AGED; ARTICLE; BATH ANKYLOSING SPONDYLITIS DISEASE ACTIVITY INDEX; COMPARATIVE STUDY; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE DURATION; EQ 5D QUESTIONNAIRE; FEMALE; FUNCTIONAL STATUS; HEALTH ASSESSMENT QUESTIONNAIRE; HEALTH STATUS; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PAIN ASSESSMENT; PRIORITY JOURNAL; PSORIASIS SEVERITY INDEX; PSORIATIC ARTHRITIS; PSORIATIC ARTHRITIS QUALITY OF LIFE QUESTIONNAIRE; SCORING SYSTEM; VISUAL ANALOG SCALE;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ARTHRITIS, PSORIATIC; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; FEMALE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 77954872108     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009740903468982     Document Type: Article

References (24)

1. Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64(Suppl 2):ii14-17.
2. Bansback NJ, Regier DA, Ara R, Brennan A, Shojania K, Esdaile JM, et al. An overview of economic evaluations for drugs used in rheumatoid arthritis: focus on tumour necrosis factor-alpha antagonists. Drugs 2005;65:473-496
3. McKenna SP, Doward LC, Whalley D, Tennant A, Emery P, Veale DJ. Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis 2004;63:162-169 (Pubitemid 38122135)
4. Healy PJ, Helliwell PS. Psoriatic arthritis quality of life instrument: an assessment of sensitivity and response to change. J Rheumatol 2008;35:1359-1361
5. Marzo-Ortega H, McGonagle D, Rhodes LA, Tan AL, Conaghan PG, O'Connor P, et al. Efficacy of infliximab on MRI-determined bone oedema in psoriatic arthritis. Ann Rheum Dis 2007;66:778-781
6. Bravo Vergel Y, Hawkins NS, Claxton K, Asseburg C, Palmer S, Woolacott N, et al. The cost-effectiveness of etanercept and inflix- imab for the treatment of patients with psoriatic arthritis. Rheumatology (Oxford) 2007;46:1729-1735
7. Tammaru M, Lember M, Polluste K, McKenna SP. Cultural adaptation of quality of life measures. Scand J Rheumatol 2007;36:406-407
8. Lovas K, Koo E, Whalley D, Meads D, Kalo Z, McKenna SP. [The validation of a disease specific quality of life instrument in patients with psoriatic arthritis], in Hungarian. LAM 2002;12:389-395
9. Szende A, Nemeth R. [Health-related quality of life of the Hungarian population], in Hungarian. Orv Hetil 2003;144:1667-1674
10. Mease PJ, Antoni CE, Gladman DD, Taylor WJ. Psoriatic arthritis assessment tools in clinical trials. Ann Rheum Dis 2005;64(Suppl 2):ii49-54.
11. Fredriksson T, Pettersson U. Severe psoriasis - oral therapy with a new retinoid. Dermatologica 1978;157:238-244
12. Kind P, Brooks R, Rabin R, eds. EQ-5D Concepts and Methods: A Developmental History. Dordrecht, The Netherlands: Springer; 2005.
13. Gulfe A, Kristensen LE, Saxne T, Jacobsson LT, Petersson IF, Geborek P. Rapid and sustained health utility gain in anti-TNF treated inflammatory arthritis. Observational data during seven years in southern Sweden. Ann Rheum Dis 2009 (doi:10.1136/ ard.2008.103473).
14. Brazier J, Roberts J, Tsuchiya A, Busschbach J. A comparison of the EQ-5D and SF-6D across seven patient groups. Health Econ 2004;13:873-884
15. Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 2003;30:167-178
16. Helland Y, Dagfinrud H, Kvien TK. Perceived influence of health status on sexual activity in RA patients: associations with demographic and disease-related variables. Scand J Rheumatol 2008;37:194-199
17. Hoving JL, Bartelds GM, Sluiter JK, Sadiraj K, Groot I, Lems WF, et al. Perceived work ability, quality of life, and fatigue in patients with rheumatoid arthritis after a 6-month course of TNF inhibitors: prospective intervention study and partial economic evaluation. Scand J Rheumatol 2009:38:246-250
18. Wallenius M, Skomsvoll JF, Koldingsnes W, Rodevand E, Mikkelsen K, Kaufmann C, et al. Comparison of work disability and health-related quality of life between males and females with rheumatoid arthritis below the age of 45 years. Scand J Rheumatol 2009;38:178-183
19. Husted JA, Tom BD, Farewell VT, Schentag CT, Gladman DD. A longitudinal study of the effect of disease activity and clinical damage on physical function over the course of psoriatic arthritis: does the effect change over time? Arthritis Rheum 2007;56:840-849
20. Cohen J. Statistical power for the behavioral sciences, 2nd edn. Hillsdale, NJ: Erlbaum Associates, 1988.
21. Cohen J. A power primer. Psychol Bull 1992;112:155-159
22. Linde L, Sorensen J, Ostergaard M, Horslev-Petersen K, Hetland ML. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J Rheumatol 2008;35:1528-1537
23. Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, et al. A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Sci Med 2005;60:1571-1582
24. Seymour J, McNamee P, Scott A, Tinelli M. Shedding new light onto the ceiling and floor? A quantile regression approach to compare EQ-5D and SF-6D responses. Health Econ 2009. doi:10.1002/hec.1505.